FDA Approved: EMTRICITABINE — Supplemental Application (Cipla USA Inc.)

View source ↗

Summary

FDA approves Cipla USA Inc.'s supplemental application for emtricitabine, a generic antiretroviral, finalizing changes to the product's approval.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Emtricitabine (Emtricitabine)

Snippet

SUPPL AP for EMTRICITABINE (EMTRICITABINE)